Dr Tedros and Dr Swaminathan on hydroxychloroquine and the Solidarity Trial

Last week the #COVID19 Solidarity Trial Executive Group implemented a temporary pause of the hydroxychloroquine arm of the trial, because of concerns about the safety of the drug. This decision was taken as a precaution while the safety data were reviewed.

Based on available data, the #COVID19 Solidarity Trial Data Safety & Monitoring Committee recommended there are no reasons to modify the trial protocol. The Executive Group endorsed the continuation of all arms of the Trial, including the use of hydroxychloroquine.

View the entire press conference from 03 June 2020 here: https://youtu.be/JdNLqZlI7KA

More information here:

https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Leave a Comment